ZEISS AT LISA tri family
Product Family

ZEISS AT LISA tri family

Reliably providing your patients with maximum spectacle independence.

Cataract patients nowadays have very high expectations concerning their visual performance after IOL implantation. Wishing to maintain their active lifestyle into high age, they require a solution that enables them to perform most daily activities without visual aids. The AT LISA® tri family from ZEISS is the leading trifocal technology that allows you to offer your patients maximum spectacle independence.

  • Ensuring happy patients
  • Proven worldwide by your peers
  • Patient communication support
The trifocal IOLs that provide maximum spectacle independence

The trifocal IOLs that provide maximum spectacle independence

  • Two distinct additional focal points for intermediate and near distances.
  • Asymmetric light allocation to ensure best visual outcome at all three distances.
  • Pupil independent design with a trifocal center and bifocal periphery to ensure sufficient light allocation to near distances, also during mesopic conditions.
Ensuring happy patients

Ensuring happy patients

Peer-reviewed publications repeatedly demonstrate that spectacle independence is higher than 90%1 with several studies reaching full spectacle independence.2

All peer-reviewed publications investigating patient reported outcomes with ZEISS AT LISA tri confirm high levels of patient satisfaction.

Proven worldwide by your peers

Proven worldwide by your peers

ZEISS AT LISA tri is the reference trifocal IOL which has proven its performance in over 170 peer-reviewed publications. In total, more than 60 first authors from over 20 countries have published their findings on the lens.

Explore key insights from ZEISS AT LISA tri publications

  • Visual performance in a flight simulator: Multifocal intraocular lenses in pilots

    Author: Lenton, L.; Vision Eye Institute Clinic

    A clinical investigation analyzing the performance of adults with ZEISS AT LISA tri in a realistic flight simulator found that AT LISA tri patients did not experience constraints from a vision perspective in terms of ability to perform tasks in a flight simulator such as simulated landing runs in both daytime and night-time conditions.

    No of patients: 13
    Follow up time: n/a

    Reference: Lenton, L. (2018). Visual performance in a flight simulator: multifocal intraocular lenses in pilots. BMJ Open Ophthalmology.

  • Clinical outcomes following trifocal diffractive intraocular lens implantation for age-related cataract in China

    Author: Yang, Y. et al.;  Department of Ophthalmology, Peking University Third Hospital

    At 3 months postoperatively, the cohort reported a spectacle independence rate of 100%.

    No. of patients: 26
    Follow Up: 1 week, 1M, 3M

    Reference: Yang, Y. et al.(2018). Clinical outcomes following trifocal diffractive intraocular lens implantation for age-related cataract in China. Clinical Ophthalmology. Volume 2018:12 Pages 1317—1324.

  • Implantation of a diffractive trifocal intraocular lens: one-year follow-up

    Author: Mojzis, P. et al.;  Premium Clinic Teplice

    The study analyzed AT LISA tri’s performance in terms of contrast sensitivity and found that patient outcomes are in the normal range, both in photopic as well as mesopic conditions.

    No. of Patients: 60

    Reference: Mojzis, P. et al. (2015). Visual Outcomes of a new toric trifocal diffractive intraocular lens. JCRS, 41(12): 2695-2706

  • Clinical Outcomes after Binocular Implantation of a New Trifocal Diffractive Intraocular Lens

    Authors: Kretz, F. et al.;  Augenklinik Ahaus-Raesfeld-Rheine

    All patients (100%) were satisfied in terms of their ability to read, their intermediate and distance vision, their quality of vision at all distances, and their independence of spectacles for performing their daily activities and for the use of computer.

    No. of patients: 38
    Follow Up: 3M

    Reference: Kretz, F. et al. (2015). Clinical Outcomes after Binocular Implantation of a New Trifocal Diffractive Intraocular Lens. Journal of Refractive Surgery. 2015;31(8):504-510.

  • Long-term visual outcomes and patient satisfaction following bilateral implantation of trifocal intraocular lenses

    Authors: Ganesh, S. et al.;  Nethradhama Superspeciality Eye Hospital

    Even under mesopic conditions patients with ZEISS AT LISA tri benefit from continuously high levels of visual acuity better than 0.1logMAR over a defocus up to -3 D, equaling a viewing distance of 33 cm. Spectacle independence rate was at 100%.
    Study

    No. of patients: 25
    Follow Up: 12M

    Reference: Ganesh, S. et al. (2017). Long-term visual outcomes and patient satisfaction following bilateral implantation of trifocal intraocular lenses. Clinical Ophthalmology, II: 1453-1459

  • Clinical outcomes of new toric trifocal diffractive intraocular lens in patients with cataract and stable keratoconus: Six months follow-up

    Authors: Farideh, D., et al.;  Eye Research Center, Tehran University of Medical Sciences

    Analyzing outcomes for AT LISA tri toric implantation in keratoconus patients, investigators found that the IOL provided appropriate distance, near and intermediate visual results. Prediction of the refractive results and optical performances were good.

    No. of patients & Follow Up: 5

    Reference: Farideh, D. et al. (2017). Clinical outcomes of new toric trifocal diffractive intraocular lens in patients with cataract and stable keratoconus: Six months follow-up. Medicine. Mar 2017; 96(12):e6340.

  • Visual performance, reading ability and patient satisfaction after implantation of a diffractive trifocal intraocular lens

    Authors: Mencucci, R. et al.;  Department of Surgery and Translational Medicine, Eye Clinic, University of Florence

    Analysis of patient satisfaction with AT LISA tri confirmed good feedback at all three distances.

    No. of patients: 21
    Follow Up: 3M

    Reference: Mencucci, R. et al. (2017). Visual performance, reading ability and patient satisfaction after implantation of a diffractive trifocal intraocular lens. Clinical Ophthalmology. Volume 2017:11 Pages 1987—1993.

  • Influence of Angle κ and Higher-Order Aberrations on Visual Quality Employing Two Diffractive Trifocal IOLs

    Authors: Velasco-Barona, C et al.;  Anterior Segment Surgery Department, Asociación para Evitar la Ceguera

    The study found “no associations between angle k distance and postoperative visual acuity regardless of the angle k magnitude”.

    No. of patients & Follow Up: 20

    Reference: Velasco-Barona, C. et al. (2019). Influence of Angle κ and Higher-Order Aberrations on Visual Quality Employing Two Diffractive Trifocal IOLs. Journal of Ophthalmology. Volume 2019.

  • Comparison of visual outcomes and subjective visual quality after bilateral implantation of a diffractive trifocal intraocular lens and blended implantation of apodized diffractive bifocal intraocular lenses.

    Authors: Gundersen, K. and Potvin, R.;  IFocus Øyeklinikk

    Gundersen and Potvin highlight superiority of bilateral implantation of AT LISA tri vs mono-vision with competitor bifocal IOLs, in particular at intermediate distances where a statistically significant better VA outcome was found from 2m to 67cm.

    No. of patients & Follow up time: 55 (25 patients trifocal cohort, 30 patients bifocal cohort)

    Reference: Gundersen, K. and Potvin, R. (2016). Comparison of visual outcomes and subjective visual quality after bilateral implantation of a diffractive trifocal intraocular lens and blended implantation of apodized diffractive bifocal intraocular lenses. Clinical Ophthalmology; 2016 Mar 17;10:805-811.

  • Comparison of visual outcomes of 2 diffractive trifocal intraocular lenses

    Authors: Marques, E. and Ferreira, T.;  Cruz Vermelha Hospital

    100% of AT LISA tri patients in this study achieved spectacle independence.

    No. of patients: 30
    Follow up time: 3M

    Reference: Marques, E. and Ferreira, T. (2015). Comparison of visual outcomes of 2 diffractive trifocal intraocular lenses. JCRS. Volume 41, Issue 2, February 2015, Pages 354-363.

  • Refractive results with the use of AT.Lisa intraocular lens (2008-2015)

    Authors: Filip, M. et al.;  AmaOptimex Eye Clinic

    “In the overall estimation, 90,19% of the patients were happy, in 7,84% of cases, the result was satisfactory and 1,96% were unhappy due to miodesopsias.”

    No. of patients: 102

    Reference: Filip, M. et al. (2016). Refractive results with the use of AT.Lisa intraocular lens (2008-2015). Romanian Journal of Ophthalmology, Volume 60, Issue 1, January-March 2016. pp:18-20.

  • Visual outcomes and patient satisfaction after bilateral implantation of a new trifocal diffractive intraocular lens

    Authors:  Almulhim, A. et al.;  Department of Ophthalmology, Aljouf University

    Patients achieved very high spectacle independence at all three distances, with distance reaching 95%, intermediate 98% and near 100%.

    No. of patients: 41
    Follow up: 3M

    Reference: Almulhim, A. et al., (2018). Visual outcomes and patient satisfaction after bilateral implantation of a new trifocal diffractive intraocular lens. Saudi Journal of Ophthalmology. Volume 32, 310–317.

  • Clinical Outcomes of Combined Implantation of an Extended Depth of Focus IOL and a Trifocal IOL in a Korean Population

    Authors: Song, J.E. et al.;  Department of Ophthalmology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

    Patients with combined implantation of AT LARA (EDoF IOL) and AT LISA tri (trifocal IOL) achieved better visual acuity results at intermediate and near distances without compromising far distance vision compared to the monocular outcomes of each IOL. The combined implantation of an EDoF and a trifocal IOL can be a viable option for patients with high demands for spectacle independence in their daily life with minimal optical phenomena.

    No. of patients: 25
    Follow-up: 6M

    Reference: Song, J.E. et al. (2021): Clinical Outcomes of Combined Implantation of an Extended Depth of Focus IOL and a Trifocal IOL in a Korean Population,  Journal of Ophthalmology.

  • Visual Outcomes Following Bilateral lmplantation of Two Diffractive Trifocal IOLs in 10.084 eyes

    Authors: Bilbao-Calabuig, R. et al.;  Clinica Baviera Madrid, lnstituto Oftalmologico Europeo

    In a comparative study with >4.000 patients per group, higher patient satisfaction was found with AT LISA tri than with FineVision.

    No. of patients: 2141
    Follow up time: 3M

    Reference: Bilbao-Calabuig, R. et al. (2017) Visual Outcomes Following Bilateral Implantation of Two Diffractive Trifocal IOLs in 10 084 eyes. Ophthalmology 2017;179:55-66.

  • Clinical outcomes with a new trifocal intraocular lens

    Authors:  Law, E. et al.;  BMI Southend Private Hospital

    AT LISA tri provides excellent uncorrected distance, intermediate, and near visual outcomes. Even for small print activities such as reading labels, no patient experienced tasks as very difficult.

    No. of patients: 30
    Follow up time: 1M, 3M & 6M

    Reference: Law, E. et al. (2013). Clinical outcomes with a new trifocal intraocular lens. European Journal of Ophthalmology. Volume: 24 issue: 4, page(s): 501-508

Patient communication support

Patient communication support

ZEISS provides a wide range of patient educational and promotional materials to support your communication with patients.

The patient tools for ZEISS AT LISA tri family help you to explain the trifocal technology and its benefits to your patients, facilitating the process of offering premium solutions for cataract treatment.

Tools for the entire patient journey

ZEISS patient communication materials include a range of print brochures, videos, digital tools and visualization models for use in patient education and consultation process.

ZEISS also provides you with the possibility to personalize the promotional patient material with your clinic's logo.

ZEISS Vision Simulation Tool

Vision simulation tool

This interactive tool enables you to explain the different IOL categories by simulating the pre- and postsurgical visual experience. It helps you to guide your patients through the decision for the IOL type, providing the best individual fit. Start integrating the Vision Simulation Tool into your patient consultation now!

Publications

    • AT LISA tri 839MP Study Spotlight Far distance retinal image quality Jorge L. Alio 2022

      130 KB
    • AT LISA tri & AT LARA mix and match Study spotlight EN

      386 KB
    • AT LISA tri 839MP Study Spotlight 6-year Visual Outcomes EN

      173 KB




Testimonials

    • Dr. Matteo Piovella

      Dr. Matteo Piovella,
      Monza, Italy

    • Ms. Inger Madsen

      Ms. Inger Madsen,
      Aarhus, Denmark

    • Dr. Daniel Ovalles Melgem

      Dr. Daniel Ovalles Melgem,
      Culiacán, Mexico

    • Dr. Pablo Luis Daponte

      Dr. Pablo Luis Daponte,
      Buenos Aires, Argentina

    • President (2010-Present) of the Italian Society of Ophthalmology, Dr. Matteo Piovella, has implanted the first AT LISA tri to his patients in 2012. Two years later, after witnessing the successful visual outcomes derived from the trifocal IOL, he decided to have the same surgery himself and have AT LISA tri implanted in his own eyes. Watch the video to know which aspects of his personal and professional life changed for the best after the surgery.
      Dr. Matteo Piovella, Monza, Italy
    • Ms. Inger Madsen is an ophthalmic OR nurse working in an eye clinic in Aarhus (Denmark). After years of discomfort wearing glasses, she wanted to improve the quality of her life and decided to be implanted with AT LISA tri in 2013. Dr. Michael Lindholdt, surgeon and owner of the clinic where Ms. Madsen works, performed her surgery. In this video, we hear the unique perspective of both patient and doctor.
      Ms. Inger Madsen, Aarhus, Denmark
    • Dr. Daniel Ovalles Melgem was implanted with ZEISS AT LISA tri in October 2020. Before opting for surgery in his own eyes, he had difficulties reading close-up and performing surgery. After 10 years of successful implantations with AT LISA tri and happy patients, he was sure that AT LISA tri was the right choice for himself and his loved ones.
      Dr. Daniel Ovalles Melgem, Culiacán, Mexico
    • In 2019, Dr. Pablo Luis Daponte was implanted with ZEISS AT LISA tri. As someone who enjoys outdoor activities and water sports, Dr. Daponte was determined to find a solution that would allow him to continue pursuing his profession and passions without limitations.
      Dr. Pablo Luis Daponte, Buenos Aires, Argentina
    • Dr. Jørn S. Jørgensen

      Dr. Jørn S. Jørgensen,
      Hamburg, Germany

    • Dr. Frank Kerkhoff

      Dr. Frank Kerkhoff, Eersel, Netherlands

    • Dr. Zhang Shunhua

      Dr. Zhang Shunhua,
      Beijing, China

    • Dr. Durval M. Carvalho Jr.

      Dr. Durval M. Carvalho Jr.,
      Brasília, Brazil

    • Dr. Carlos Rocha de Lossada

      Dr. Carlos Rocha de Lossada,
      Almeria, Spain

    • Having implanted 20,000 ZEISS AT LISA tri IOLs himself, Dr. Jørn S. Jørgensen, Chairman, CEO and Founder of EuroEyes International, shares his long-standing expertise on IOL surgery and patient consultation.
      Dr. Jørn S. Jørgensen, Hamburg, Germany
    • Dr. Frank Kerkhoff – Cataract, refractive and vitreoretinal surgeon from FYEO Medical - on the advantage of the Day 1 visual experience with ZEISS AT LISA tri and how this contributes to the long-term patient satisfaction.
      Dr. Frank Kerkhoff, Eersel, Netherlands
    • Dr. Zhang Shunhua - Cataract surgeon from the Peking Union Medical College Hospital - on her experience in implanting ZEISS AT LISA tri and how realizing the vision dreams of her patients became a priority and a mission in her daily work.
      Dr. Zhang Shunhua, Beijing, China
    • Dr. Durval - Cataract and Glaucoma surgeon and vice president of the Brazilian Cataract and Refractive Surgery Association - on the patients´ post-operative success stories and visual long-term performance of ZEISS AT LISA tri.
      Dr. Durval M. Carvalho Jr., Brasília, Brazil
    • This peer-reviewed publication is the longest study, reviewing Long-Term Efficacy, Visual Performance and Patient Reported Outcomes with Trifocal Intraocular Lenses.
      Dr. Carlos Rocha de Lossada, Almeria, Spain

Ready to unlock the full potential of your clinic?

ZEISS Premium Cataract Workflow

The ZEISS Lisa tri family could be just the beginning: Take your workflow to a new level and learn how our products and applications add value beyond the mere sum of their parts.

Are you a patient?

Please visit our patient website for more information on cataract treatment:

Downloads

    • AT LISA tri 839MP & AT LISA tri toric 949M/MP Datasheet EN

      117 KB




    • AT LISA tri 839MP/939 & 949M/MP Clinical Leaflet EN

      767 KB


Specification comparison

ZEISS AT LISA tri family

ZEISS AT LISA tri 839MP
ZEISS AT LISA tri toric 949M/MP
Optic Design
Trifocal, diffractive, +3.33 D near add and +1.66 D intermediate add at the IOL plane, aspheric (aberration correcting)
Trifocal, bitoric, diffractive, +3.33 D near add and +1.66 D intermediate add at the IOL plane, aspheric (aberration correcting)
Company Labeled A-Constant
118.6
118.8
Diopter Range

0.0 to +32.0 D, 0.5 D increments3

Spherical Equivalent (SE): -5.0 to +35.0 D, 0.5 D increments3

Cylinder: +1.0 to +12.0 D, 0.5 D increments3

ACD

5.26

5.39
Injector/Cartridge Set

BLUEMIXS® 180

BLUEMIXS® 180
VISCOJECT-BIOTM 2.2

Indications
Indicated for the visual correction of aphakia secondary to the removal of the crystalline lens in patients with cataract
Indicated for the visual correction of aphakia secondary to the removal of the crystalline lens in patients with cataract
Also indicated for non-cataractous, presbyopic patients who seek greater independence from glasses for intermediate and/or near distances
Also indicated for non-cataractous, presbyopic patients who seek greater independence from glasses for intermediate and/or near distances
ZEISS toric IOL are also indicated for the correction of regular corneal astigmatism
Material
Hydrophilic acrylic (25 %) with hydrophobic surface properties
Hydrophilic acrylic (25 %) with hydrophobic surface properties
Optic Diameter
6.0 mm
6.0 mm
Total Diameter
11.0 mm
11.0 mm
Haptic Angulation
Lens Design
Single-piece, MICS
Single-piece, bitoric, MICS
Incision Size
1.8 mm
1.8 mm
Implantation
Capsular Bag
Capsular Bag

Get in touch with us!

Receive more information about the product and availability in your country!

Form is loading...

Personal contact information

If you want to have more information on data processing at ZEISS please refer to our data privacy notice


  • 1

    Mendicute et al., 2016. Evaluation of visual outcomes and patient satisfaction after implantation of a diffractive trifocal intraocular lens. J Cataract Refract Surg. 2016 Feb;42(2):203-10.

  • 2

    Aggarwal RK. Clinical outcomes of different multifocal IOLs. XXV Congress of the ESCRS 2007; Stockholm, Sweden.   

  • 3

    The preloaded AT LISA tri toric 949MP is available in the diopter range: Spherical equivalent -5.0 to +32.0 D, cyl. +1.0 to + 4.0 D.
    The non-preloaded AT LISA tri toric 949M is available in the diopter ranges: Spherical equivalent -5.0 to +32.0 D, cyl. +4.5 D to +12.0 D and spherical equivalent +32.5 to +35.0 D, cyl. +1.0 to +12.0 D.